Susan E. Graf - Feb 12, 2025 Form 3 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role
Director
Signature
/s/ Nelson Sun, as Attorney-in-Fact
Stock symbol
AARD
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
3
Date filed
2/12/2025, 07:17 PM
Previous filing
Oct 7, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AARD Stock Option (Right to Buy) Feb 12, 2025 Common Stock 29.5K $7.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares subject to the option shall vest on November 14, 2025, and 1/48th of the original number of shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.

Remarks:

Exhibit 24 - Power of Attorney